Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia

Andreas Greinacher, Kathleen Selleng, Raghavendra Palankar, +28

Blood

Characterization of the human neutrophil alloantigen-3a

Andreas Greinacher, Jan Wesche, Elke Hammer, +4

Nature Medicine

InflammationImmunogeneticsGranulocyteMedicineImmunology +2

Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein

Andreas Greinacher, Kathleen Selleng, Julia Mayerle, +23

Blood

Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA

Raghavendra Palankar, Thomas P. Kohler, Krystin Krauel, +3

Journal of Thrombosis and Haemostasis

Microbial PathogensInnate Immune SystemImmunologyInnate ImmunityImmune System +14

A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination

Stefan Handtke, Martina Wolff, Carlo Zaninetti, +8

Blood

Geno‐ and phenotyping and immunogenicity of HNA‐3

Angelika Reil, Jan Wesche, Andreas Greinacher, +1

Transfusion

Role of Platelet Size Revisited—Function and Protein Composition of Large and Small Platelets

Stefan Handtke, Leif Steil, Raghavendra Palankar, +9

Thrombosis and Haemostasis

Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines

Stephan Michalik, Florian Siegerist, Raghavendra Palankar, +14

Haematologica

ImmunologyViral PathogenesisPathologyThrombocytopenia SyndromeViral Structural Protein +15

Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure

Linda Schönborn, Olga Esteban, Jan Wesche, +22

Blood

ImmunodeficienciesImmunologyPathologyImmunotherapyThrombosis +15

Towards Understanding ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)

Andreas Greinacher, Kathleen Selleng, Jan Wesche, +21

Research Square (Research Square)

ImmunologyImmunodominanceCd4 T Cell ResponsesInnate ImmunityImmune System +18